ARCHIVES

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

This article is from The Cancer Letter archive.

Vol. 11 No. 33 | August 16, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

Environmental Carcinogenesis Seen As Next Big Growth Field; NCA Hears Problems, Priorities

October 31, 1975

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007

In Brief: Kennedy To Stay On Health Committee; Animal Research Bills Probably Dead For This Congress

December 10, 1982